Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
comprehensive, favour, insider, lieu, Ministry, month, notification, Toronto
Removed:
condition, contrary, deficit, exemption, John, Molloy, requiring, voting
Filing tables
Filing exhibits
- 40-F Annual report (Canada)
- 99.1 Annual Information Form
- 99.2 Audited Consolidated Balance Sheets
- 99.3 Management's Discussion and Analysis
- 99.4 Supplemental Note: Reconciliation to U.S. Gaap
- 99.5 Consent of KPMG LLP
- 99.6 Certification (DR. Francesco Bellini)
- 99.7 Certification (Mariano Rodriguez)
- 99.8 Certification (DR. Francesco Bellini)
- 99.9 Certification (Mariano Rodriguez)
- 99.10 Code of Ethics
BLU similar filings
Filing view
External links
Exhibit 99.8
Certification of Chairman of the Board, President and Chief Executive Officer
pursuant to Title 18, United States Code, Section 1350,
as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
pursuant to Title 18, United States Code, Section 1350,
as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
I, Dr. Francesco Bellini, Chairman of the Board, President and Chief Executive Officer of Neurochem Inc., (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:
1. | The Annual Report on Form 40-F of the Company for the year ended December 31, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and | |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 14, 2008.
/s/ Francesco Bellini | ||||
Chairman of the Board, President and Chief Executive Officer |